Document is current
Any future updates will be listed below
-
Authors
Siladi, Andrew J.
Wang, Jing
Florian, Andrea C.
Thomas, Lance R.
Creighton, Joy H.
Matlock, Brittany K.
Flaherty, David K.
Lorey, Shelly L.
Howard, Gregory C.
Fesik, Stephen W.
Weissmiller, April M.
Liu, Qi
Tansey, William P.
-
Funding
Funding for this research was provided by:
National Cancer Institute (CA200709)
National Cancer Institute (CA009582)
National Cancer Institute (CA211305)
National Cancer Institute (CA68485)
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
National Cancer Center (CA257102)
National Institute of Diabetes and Digestive and Kidney Diseases (DK058404)
Rally Foundation
- License Information
-
More Information
Article History
Received: 20 September 2021
Accepted: 19 January 2022
First Online: 3 February 2022
Competing interests
: Two of the authors, Stephen Fesik and William Tansey, declare that they are inventors on the following two patents: (1) US Patent 10,160,763 “WDR5 Inhibitors and Modulators,” on December 25, 2018. (2) US Patent 10,501,466 “WDR5 Inhibitors and Modulators,” on December 10, 2019. There are no financial competing interests currently connected with these patents. None of other authors have competing interests to declare.
